Menu

About Us
GeM Registration
Company Insights

Department of Military Affairs Tender by Indian Air Force (GEM/2025/B/6161866)

HUMAN INSULINE ANALOGUE GLARGINE INJ 100IU/ML(RECOMBINANT DNA ORIGIN) 300 IU DISPOSABLE PEN WITH 5

Goods
Qty:210
Department of Military Affairs Tender by Indian Air Force (GEM/2025/B/6161866)

Tender Timeline

Tender Issue
April 28, 2025 at 12:06 PM

Tender Title: Human Insulin Analogue Glargine Injection

Reference Number: GEM/2025/B/6161866

Issuing Authority/Department: Department of Military Affairs, Ministry of Defence

The Department of Military Affairs is inviting bids for the tender concerning Human Insulin Analogue Glargine Injection 100IU/ML (Recombinant DNA Origin), specifically in the form of a 300 IU Disposable Pen. This product is essential for the management of diabetes among patients, particularly for those requiring long-acting insulin therapy. The tender seeks to source a total of 210 units of this medicinal product to ensure an uninterrupted supply for healthcare needs.

Scope of Work and Objectives

The primary objective of this tender is to procure high-quality human insulin analogue glargine injection in a specified form and volume. The successful bidder is expected to meet the technical and financial requirements in order to ensure the delivery of safe and effective insulin products.

Eligibility Criteria

To be eligible for this tender, bidders must satisfy specific criteria, including:

  • Registration as a legal entity in the pharmaceutical manufacturing sector.
  • Proof of previous experience in supplying pharmaceutical products, particularly injectable forms of insulin.
  • Compliance with relevant regulatory approvals and certifications from health authorities.

Technical Requirements

Bidders are required to demonstrate compliance with the following technical requirements:

  • Manufacturing the Insulin Glargine product in accordance with the Good Manufacturing Practices (GMP).
  • Providing evidence of certification regarding the quality of the product, including stability data and clinical efficacy.
  • Packaging must ensure stability and safety, with specifications for transport and storage.

Financial Requirements

All bidders must provide detailed financial documentation, including:

  • A clear breakdown of the pricing structure of the product per unit.
  • Evidence of the ability to meet the financial demands associated with the production and delivery.
  • Submission of Earnest Money Deposit (EMD) as specified by the tender guidelines.

Document Submission Details

Bidders should submit all required documents in a sealed envelope clearly marked with the tender reference number. The submission must include:

  • Technical proposals.
  • Financial proposals with all requisite financial documentation.
  • Any additional documents that validate compliance with eligibility and technical requirements.

Special Provisions

This tender encourages participation from Micro, Small, and Medium Enterprises (MSEs) and Startups. Specific incentives and benefits may apply to enhance the participation of these enterprises in the procurement process. Relevant details and eligibility for these provisions must be clearly outlined in the bid submission.

Evaluation Process

Proposals will be evaluated based on:

  • Compliance with technical specifications and quality standards.
  • Financial viability and competitiveness of the bid.
  • Experience and track record in the supply of similar pharmaceutical products.

Successful bidders will be notified, and the results will be publicly proclaimed via official channels.

Delivery Locations

The Human Insulin Analogue Glargine Injection must be delivered to designated healthcare facilities as specified in the tender bid documents, ensuring adherence to the specified timelines and logistical requirements.

Contact Information

For further details and clarifications related to the tender, please refer to the contact points outlined in the tender documents. All inquiries should be made in an official manner, referencing the tender name and number.

General Information

Item Category
HUMAN INSULINE ANALOGUE GLARGINE INJ 100IU/ML(RECOMBINANT DNA ORIGIN) 300 IU DISPOSABLE PEN WITH 5 N
Ministry Name
Ministry of Defence
Department Name
Department of Military Affairs
Organisation Name
Indian Air Force

Financial Information

OEM Average Turnover
₹2.00 Lakh (s)
Bid Offer Validity
180 (Days)
Past Performance
50 %
Arbitration Clause
No
Mediation Clause
No

Evaluation and Technical Information

Evaluation Method
Total value wise evaluation
RA Qualification Rule
50% Lowest Priced Technically Qualified Bidders
Inspection Required
Yes
Technical Clarifications Time
2 Days

Tender Documents

4 Documents
GeM-Bidding-7763840.pdfMain Document
Other DocumentsOTHER
Buyer uploaded ATC documentATC ATC
GEM General Terms and Conditions DocumentGEM_GENERAL_TERMS_AND_CONDITIONS

Documents Required from Seller

  • Experience Criteria
  • Past Performance
  • Certificate (Requested in ATC)
  • OEM Authorization Certificate
  • OEM Annual Turnover
  • Additional Doc 1 (Requested in ATC)
  • Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
  • the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer

Similar Tenders

View All

D IFA RE 21 Human Insulin Analogue Long acting basal Inj 100 IU ml Recombinant DNA origin 300 IU Di

₹158.00
GEM
Goods
Qty:11.6K
6 Files
Indian Army
DARJEELING, WEST BENGAL
Boq › Boql
D IFA RE 21 Human Insulin Analogue Long acting basal Inj 100 IU ml Recombinant DNA origin 300 IU Disposable Pen with 5 needles per pen , D IFA RE 21 Gliclazide MR 30 mg Tab , D IFA RE 21 Glipizide 5mg Tab , D IFA RE 21 Sitagliptin 50 mg Metformin 1000 mg Tab , D IFA RE 21 Insulin Lispro Biphasic injection I DOT P 25 Insulin Lispro and 75 Insulin Lispro protamine suspension , D IFA RE 21 Sirolimus 1mg Tab , D IFA RE 21 Pioglitazone Hydrochloride 15mg Tab , D IFA RE 21 Alendronate Sodium 70mg Tab , D IFA RE 21 Neostigmine 0 DOT 5mg 1ml Inj , D IFA RE 21 Cisatracurium 2 mg ml Inj 10ml vial , D IFA RE 21 Tacrolimus 1mg Prolonged Release Cap , D IFA RE 21 Mycophenolate Mofetil 750mg Tab , D IFA RE 21 Intravenous Immunoglobulin IvIg 10gm Bott of 50ml , D IFA RE 21 Calcium Phosphate 0 DOT 24 mg 5 ml Syp , D IFA RE 21 Calcium Acetate 500 mg Tab , D IFA RE 21 Carnitine 200 mg Tab , D IFA RE 21 Acyclovir Ophth Ointment 3 w w in 5 gm tube , D IFA RE 21 Ciprofloxacin HCl 0 DOT 3 Tube of 5 gm , D IFA RE 21 Ciprofloxacin HCl 0 DOT 3 Dexamethasone DOT 1 bott of 5ml , D IFA RE 21 Cyclosporine eye drop 0 DOT 05 bott of 3 ml , D IFA RE 21 Fluorescein Sodium 20 3 ml Inj , D IFA RE 21 Flurbiprofen Sodium ophthalmic soln 0 DOT 03 vial of 5 ml , D IFA RE 21 Homatropine Hydrochloride Soln 2 , D IFA RE 21 Ketorolac Tromethamine 0 DOT 4 Eye drops , D IFA RE 21 Natamycin 3 eye drops in 3 ml bott , D IFA RE 21 Carboxy Methyl Cellulose CMC 1 Gel , D IFA RE 21 Ofloxacin 0 DOT 3 bott of 5 ml , D IFA RE 21 Pilocarpine Nitrate eye solution 2 bott of 5 ml , D IFA RE 21 Pilocarpine Intracameral Inj 0 DOT 5 Pilocarpine nitrate intra ocular Inj without preservatives amp of 01ml each , D IFA RE 21 Prednisolone acetate 1 w v bott of 5 ml , D IFA RE 21 Sodium Chloride 6 w w ointment Tube of 3 gm , D IFA RE 21 Azelaic acid 20 cream tube of 15 gm , D IFA RE 21 Cream Luliconazole tube of 15 gm , D IFA RE 21 Tobramycin 0 DOT 3 bott of 5 ml , D IFA RE 21 Tropicamide 1 with 5 Phenylephrine eye drops bott of 5 ml , D IFA RE 21 Tropicamide Eye solution 1 bott of 5 ml , D IFA RE 21 Trypan Blue 0 DOT 6 Inj in vial of 1ml , D IFA RE 21 Amphotericin B 0 DOT 5 eye drops bott of 5 ml , D IFA RE 21 Atropine Sulphate 1 w v Eye Drop Bott of 3 ml , D IFA RE 21 Atropine Sulphate Oint 1 Tube of 3gm , D IFA RE 21 Olopatadine Hydrochloride 0 DOT 1 Ophthalmic Soln Bott of 5ml , D IFA RE 21 Olopatadine 0 DOT 2 Ophthalmic Soln bott of 5 ml , D IFA RE 21 Proparacaine Eye Drops 0 DOT 5 Bott of 5 ml , D IFA RE 21 Moxifloxacin HCl 0 DOT 5 and Dexamethasone 0 DOT 1 Ophthalmic Soln Bott of 5ml , D IFA RE 21 Diphenhydramine 10 15 mg per 5 ml and Ammonium Chloride 100 150 mg Sodium Citrate 50 85 mg per 5ml Syp Bott of 100ml , D IFA RE 21 Beclomethasone Dipropionate nasal spray 50 mcg per dose metered dose 150 units , D IFA RE 21 Betahistine Dihydrochloride 16mg Tab , D IFA RE 21 Clotrimazole 1 w v IP Lignocaine 2 w v IP ear drop bott of 10ml , D IFA RE 21 Chloramphenicol 5 w v Clotrimazole 1 w v Betamethasone 0 DOT 25 w v Lignocaine HCl 2 w v in bott of 5 ml , D IFA RE 21 Xylometazoline HCl 0 DOT 05 w v nasal solution for paed use bott of 10ml
April 30, 2025
May 22, 2025 at 10:00 AM
View Details

MITOMYCIN C 40 MG INJ,Recombinant Human Growth Hormone 5 mg to 15 mg Inj or equivalent in IUs,Caspo

₹544.00
GEM
Goods
Qty:10.4K
4 Files
Indian Army
PUNE, MAHARASHTRA
Boq › Boql
MITOMYCIN C 40 MG INJ , Recombinant Human Growth Hormone 5 mg to 15 mg Inj or equivalent in IUs , Caspofungin 50 mg per 10 ml Inj in 10 ml vial , COLISTIMETHATE SODIUM 2 MU per ML INJ , COLISTIMETHATE SODIUM 1 MU per ML INJ , INJ INTERFERON BETA 1A 30 MCG 6 MILLION IU 0.5 MI R DNA ORIGIN PREFILLED SYRINGS and PREFILLED PEN AVONEX , ZOLMITRIPTAN NASAL SPRAY 5MG 7 METERED DOSES , SODIUM PHOSPHATE SOLUTION 45 ML EACH PACK OF 2 BOTTLE , N BUTYL CYANOACRYLATE 0 5ML INJ
April 30, 2025
May 21, 2025 at 2:00 PM
View Details

Succinylchloline Chloride 50 mg per ml, 2 ml Inj,Cap Tacrolimus 0.25 mg,Flavoxate 200mg Tab,Erythro

GEM
Goods
Qty:47.3K
4 Files
Indian Navy
UTTARA KANNADA, KARNATAKA
Boq › Boql
Succinylchloline Chloride 50 mg per ml, 2 ml Inj , Cap Tacrolimus 0.25 mg , Flavoxate 200mg Tab , Erythropoeitin Human Recombinant 4000 IU , Papaverine Hydrochloride 50 mg, 2 ml Inj , Sevelamer Carbonate Sachet 800mg , Human Insulin Analogue Glargine Inj, 100 IU per ml, Recombinant DNA origin, 300 IU disposable pen with 5 needles per pen , Gentamicin sulphate 0.3 percent, gentamicin base with Hydrocortisone acetate IP 1 percent weight in volume eye and ear drops bott of 5 ml , Brimonidine Tartrate 0.2 percent, Eye drops , Clobazam 5 mg Tab , Lorazepam 2 mg per ml, 2 ml Inj , Gabapentin 300 mg Cap or Tab , Sodium Valproate 100 mg per ml Inj , Lamotrigine 25 mg Tab , Sumatriptan 50 mg Tab , Topiramate 25 mg Tab , Nimodipine 30 mg Tab , Canagliflozin 100mg tab , Carbimazole 20 mg Tab , Tab Tenofovir 300mg , Tab Entacavir 0.5mg , Omeprazole 20 mg Cap , Pantoprazole 40mg Inj , Ranitidine HCl 50 mg, 2 ml Inj , Metoclopramide syrup 5mg per 5ml bott of 30ml , Hydrocortisone Enema 10 percentage , Dicyclomine HCl 20 mg Inj , Tab or Cap Dicyclomine 10mg , Bisacodyl 5 mg Tab , Sodium phosphate solution 45 ml, each Pack of 2 bottle , Tab Dapagliflozin 10mg , Iron Syp Pediatric Each 5 ml Containing elemental iron of 50 mg as iron polymaltose complex in 200 m... , Baclofen XL 30 mg Tab , Clozapine 50 mg Tab , Ranolazine 500 mg Tab , Oral Contraceptive Pills-Mala D Ethinyl Estradiol 0.03 mg, Norgestrel 0.30 mg Tab
April 25, 2025
May 16, 2025 at 10:00 AM
View Details

Human Insulin Analogue Glargine Recombinant DNA origin 450 IU or 1 point 5 ml PFS Disposable Pen wi

₹2,520.00
GEM
Goods
Qty:4,330
4 Files
Dg Armed Forces Medical Service
KANNUR, KERALA
Boq › Boql
Human Insulin Analogue Glargine Recombinant DNA origin 450 IU or 1 point 5 ml PFS Disposable Pen with 5 needles per pen , Insulin Glulisine Injection Cartridge 100 IU or ml of 03 ml , Inj Insulin Aspart 100 U or ml of 3 Ml Pen , Insulin Aspart 50 percent plus Protamin Crystallised Aspart 50 percent 100 Iu or Ml of 3Ml Pen , Insulin Humalog Lispro Inj Recombinan Dna Origin 100 IU or ml of 3 ml cartridge , Soluble Insulin Injection 40 IU or ml of Human Actrapid Vial of 10 ml
April 24, 2025
May 15, 2025 at 5:00 PM
View Details

Frequently Asked Questions

The eligibility requirements include being a registered entity in the pharmaceutical manufacturing sector, having prior experience in supplying injectable pharmaceuticals, and obtaining necessary regulatory approvals. Bidders must provide evidence of compliance with these criteria to ensure their bid is considered.

Bidders must present certifications that demonstrate compliance with Good Manufacturing Practices (GMP), along with any approvals from relevant health authorities. Quality certifications based on stability studies and product efficacy must also be included in the tender submission to confirm adherence to industry standards.

To register for participating in this tender, entities need to ensure legal registration within the pharmaceutical manufacturing domain. This involves submitting valid operating licenses, tax registrations, and any other relevant documentation that may be mandated by the Department of Military Affairs.

Bidders are generally required to provide documents in PDF format to maintain integrity throughout the evaluation process. Additionally, documents may need to be accompanied by original certificates in hard copy, ensuring that all submissions are clear and legible.

The payment terms for this tender will be discussed and outlined in the final agreement upon selection of the successful bidder. Typically, terms may include advance payments upon confirmation of order, payment on delivery, and adherence to specified schedules to ensure timely completion of financial obligations.

This structured and comprehensive approach ensures that all necessary details are conveyed properly, catering to both potential bidders and stakeholders involved in the procurement process.

Probable Bidders

Companies likely to bid

Get Tender Alerts

Get notifications for similar tenders